[1] |
Sundar S, Chakravarty J. Antimony toxicity. Int J Environ Res Public Health, 2010; 7, 4267−77. |
[2] |
Höck A, Demmel U, Schicha H, et al. Trace element concentration in human brain: activation analysis of cobalt, iron, rubidium, selenium, zinc, chromium, silver, cesium, antimony and scandium. Brain, 1975; 98, 49−64. |
[3] |
Tanu T, Anjum A, Jahan M, et al. Antimony-induced neurobehavioral and biochemical perturbations in mice. Biol Trace Elem Res, 2018; 186, 199−207. |
[4] |
Wang XK, Zhu PY, Xu SY, et al. Antimony, a novel nerve poison, triggers neuronal autophagic death via reactive oxygen species-mediated inhibition of the protein kinase B/mammalian target of rapamycin pathway. Int J Biochem Cell Biol, 2019; 114, 105561. |
[5] |
Mao JM, Yang JB, Zhang Y, et al. Arsenic trioxide mediates HAPI microglia inflammatory response and subsequent neuron apoptosis through p38/JNK MAPK/STAT3 pathway. Toxicol Appl Pharmacol, 2016; 303, 79−89. |
[6] |
Phuagkhaopong S, Ospondpant D, Kasemsuk T, et al. Cadmium-induced IL-6 and IL-8 expression and release from astrocytes are mediated by MAPK and NF-κB pathways. Neurotoxicology, 2017; 60, 82−91. |
[7] |
Maiuolo J, Macrì R, Bava I, et al. Myelin disturbances produced by sub-toxic concentration of heavy metals: the role of oligodendrocyte dysfunction. Int J Mol Sci, 2019; 20, 4554. |
[8] |
Daneman R, Prat A. The blood-brain barrier. Cold Spring Harb Perspect Biol, 2015; 7, a020412. |
[9] |
Blanco-Suárez E, Caldwell ALM, Allen NJ. Role of astrocyte-synapse interactions in CNS disorders. J Physiol, 2017; 595, 1903−16. |
[10] |
Dossi E, Vasile F, Rouach N. Human astrocytes in the diseased brain. Brain Res Bull, 2018; 136, 139−56. |
[11] |
Carter SF, Herholz K, Rosa-Neto P, et al. Astrocyte biomarkers in Alzheimer’s disease. Trends Mol Med, 2019; 25, 77−95. |
[12] |
Jiao M, Yin KZ, Zhang T, et al. Effect of the SSeCKS-TRAF6 interaction on gastrodin-mediated protection against 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced astrocyte activation and neuronal death. Chemosphere, 2019; 226, 678−86. |
[13] |
Chen XX, Nie XK, Mao JM, et al. Perfluorooctane sulfonate mediates secretion of IL-1β through PI3K/AKT NF-кB pathway in astrocytes. Neurotoxicol Teratol, 2018; 67, 65−75. |
[14] |
Guénette SY. Astrocytes: a cellular player in Aβ clearance and degradation. Trends Mol Med, 2003; 9, 279−80. |
[15] |
Kondylis V, Kumari S, Vlantis K, Pasparakis M. The interplay of IKK, NF-κB and RIPK1 signaling in the regulation of cell death, tissue homeostasis and inflammation. Immunol Rev, 2017; 277, 113−27. |
[16] |
Dresselhaus EC, Meffert MK. Cellular specificity of NF-κB function in the nervous system. Front Immunol, 2019; 10, 1043. |
[17] |
Wan CH, Zhang Y, Jiang JK, et al. Critical role of TAK1-dependent nuclear factor-κB signaling in 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced astrocyte activation and subsequent neuronal death. Neurochem Res, 2015; 40, 1220−31. |
[18] |
Liu XH, Buffington JA, Tjalkens RB. NF-κB-dependent production of nitric oxide by astrocytes mediates apoptosis in differentiated PC12 neurons following exposure to manganese and cytokines. Mol Brain Res, 2005; 141, 39−47. |
[19] |
Dieter MP, Jameson CW, Elwell MR, et al. Comparative toxicity and tissue distribution of antimony potassium tartrate in rats and mice dosed by drinking water or intraperitoneal injection. J Toxicol Environ Health, 1991; 34, 51−82. |
[20] |
Zhao XY, Jin Y, Yang LJ, et al. Promotion of SIRT1 protein degradation and lower SIRT1 gene expression via reactive oxygen species is involved in Sb-induced apoptosis in BEAS-2b cells. Toxicol Lett, 2018; 296, 73−81. |
[21] |
Zhao XY, Wu YF, Li JL, et al. JNK activation-mediated nuclear SIRT1 protein suppression contributes to silica nanoparticle-induced pulmonary damage via p53 acetylation and cytoplasmic localisation. Toxicology, 2019; 423, 42−53. |
[22] |
Piccolini VM, Esposito A, Dal Bo V, et al. Cerebellum neurotransmission during postnatal development: [Pt(O,O'-acac)(γ-acac)(DMS)] vs. cisplatin and neurotoxicity. Int J Dev Neurosci, 2015; 40, 24−34. |
[23] |
Baldin V, Lukas J, Marcote MJ, et al. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev, 1993; 7, 812−21. |
[24] |
Dietrich DR. Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation. Crit Rev Toxicol, 1993; 23, 77−109. |
[25] |
Olabarria M, Goldman JE. Disorders of astrocytes: alexander disease as a model. Annu Rev Pathol, 2017; 12, 131−52. |
[26] |
Oliveira LFG, Souza-Silva F, Cysne-Finkelstein L, et al. Evidence for Tissue Toxicity in BALB/c Exposed to a Long-Term Treatment with Oxiranes Compared to Meglumine Antimoniate. Biomed Res Int, 2017; 2017, 9840210. |
[27] |
Saghazadeh A, Rezaei N. Systematic review and meta-analysis links autism and toxic metals and highlights the impact of country development status: higher blood and erythrocyte levels for mercury and lead, and higher hair antimony, cadmium, lead, and mercury. Prog Neuro-Psychopharmacol Biol Psychiatry, 2017; 79, 340−68. |
[28] |
Gerhardsson L, Lundh T, Minthon L, et al. Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease. Dement Geriatr Cogn Disord, 2008; 25, 508−15. |
[29] |
Alimonti A, Ristori G, Giubilei F, et al. Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis. NeuroToxicology, 2007; 28, 450−6. |
[30] |
Burda JE, Bernstein AM, Sofroniew MV. Astrocyte roles in traumatic brain injury. Exp Neurol, 2016; 275, 305−15. |
[31] |
Sofroniew MV. Astrogliosis. Cold Spring Harb Perspect Biol, 2014; 7, a020420. |
[32] |
Brenner M. Role of GFAP in CNS injuries. Neurosci Lett, 2014; 565, 7−13. |
[33] |
Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci, 2009; 32, 638−47. |
[34] |
Mann KK, Davison K, Colombo M, et al. Antimony trioxide-induced apoptosis is dependent on SEK1/JNK signaling. Toxicol Lett, 2006; 160, 158−70. |
[35] |
Ge X, Zhang DM, Li MM, et al. Microglial LOX-1/MAPKs/NF-κB positive loop promotes the vicious cycle of neuroinflammation and neural injury. Int Immunopharmacol, 2019; 70, 187−200. |
[36] |
Huang RR, Zhang Y, Han B, et al. Circular RNA HIPK2 regulates astrocyte activation via cooperation of autophagy and ER stress by targeting MIR124-2HG. Autophagy, 2017; 13, 1722−41. |
[37] |
Han B, Zhang Y, Zhang YH, et al. Novel insight into circular RNA HECTD1 in astrocyte activation via autophagy by targeting MIR142-TIPARP: implications for cerebral ischemic stroke. Autophagy, 2018; 14, 1164−84. |
[38] |
Rothhammer V, Mascanfroni ID, Bunse L, et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med, 2016; 22, 586−97. |
[39] |
Zhang Y, Huang RR, Cheng MJ, et al. Gut microbiota from NLRP3-deficient mice ameliorates depressive-like behaviors by regulating astrocyte dysfunction via circHIPK2. Microbiome, 2019; 7, 116. |
[40] |
Colombo E, Farina C. Astrocytes: key regulators of neuroinflammation. Trends Immunol, 2016; 37, 608−20. |
[41] |
Chen WW, Zhang X, Huang WJ. Role of neuroinflammation in neurodegenerative diseases (Review). Mol Med Rep, 2016; 13, 3391−96. |
[42] |
Eddleston M, Mucke L. Molecular profile of reactive astrocytes-implications for their role in neurologic disease. Neuroscience, 1993; 54, 15−36. |
[43] |
John GR, Lee SC, Brosnan CF. Cytokines: powerful regulators of glial cell activation. Neuroscientist, 2003; 9, 10−22. |
[44] |
Farina C, Aloisi F, Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol, 2007; 28, 138−45. |
[45] |
Min KJ, Yang MS, Kim SU, et al. Astrocytes induce hemeoxygenase-1 expression in microglia: a feasible mechanism for preventing excessive brain inflammation. J Neurosci, 2006; 26, 1880−7. |
[46] |
Frost GR, Li YM. The role of astrocytes in amyloid production and Alzheimer's disease. Open Biol, 2017; 7, 170228. |
[47] |
Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol, 2010; 119, 7−35. |
[48] |
Vargas MR, Johnson DA, Sirkis DW, et al. Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J Neurosci, 2008; 28, 13574−81. |
[49] |
Chen YM, Vartiainen NE, Ying WH, et al. Astrocytes protect neurons from nitric oxide toxicity by a glutathione-dependent mechanism. J Neurochem, 2001; 77, 1601−10. |